Johnson Johnson (Germany) Top Insiders
| JNJ Stock | EUR 188.42 3.36 1.82% |
Johnson Johnson employs about 152.7 K people. The company is managed by 10 executives with a total tenure of roughly 40 years, averaging almost 4.0 years of service per executive, having 15270.0 employees per reported executive. Examination of Johnson Johnson's management performance can provide insight into the company performance.
| Alex Gorsky Chairman Chairman of the Board, CEO |
| Joaquin Duato Chairman Executive Vice President Worldwide Chairman - Pharmaceuticals |
Johnson |
Johnson Johnson Management Team Effectiveness
The company has return on total asset (ROA) of 0.0871 % which means that it generated a profit of $0.0871 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2379 %, meaning that it generated $0.2379 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities.Johnson Johnson has a total of 2.6 Billion outstanding shares. The majority of Johnson Johnson outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Johnson Johnson to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Johnson Johnson. Please pay attention to any change in the institutional holdings of Johnson Johnson as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Johnson Johnson in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Johnson Johnson, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Johnson Johnson Workforce Comparison
Johnson Johnson is currently regarded as number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is currently estimated at about 248,084. Johnson Johnson totals roughly 152,700 in number of employees claiming about 62% of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27. Johnson Johnson Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Johnson Johnson Price Series Summation is a cross summation of Johnson Johnson price series and its benchmark/peer.
Johnson Johnson Notable Stakeholders
A Johnson Johnson stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Johnson Johnson often face trade-offs trying to please all of them. Johnson Johnson's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Johnson Johnson's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Alex Gorsky | Chairman of the Board, CEO | Profile | |
| Joaquin Duato | Executive Vice President Worldwide Chairman - Pharmaceuticals | Profile | |
| Jennifer Taubert | Executive Vice President - Worldwide Chairman, Pharmaceuticals | Profile | |
| Peter Fasolo | Vice President - Global Human Resources | Profile | |
| Dirk Brinckman | Chief Officer | Profile | |
| Robert Decker | Controller Officer | Profile | |
| Jessica Moore | VP Relations | Profile | |
| Joseph CPA | Ex CFO | Profile | |
| James Swanson | Ex Officer | Profile | |
| Elizabeth Forminard | Exec Counsel | Profile |
About Johnson Johnson Management Performance
The success or failure of an entity such as Johnson Johnson often depends on how effective the management is. Johnson Johnson management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Johnson management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Johnson management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Johnson Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. Johnson Johnson was founded in 1886 and is based in New Brunswick, New Jersey. JOHNSON JOHNSON operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 136000 people.
Johnson Johnson Workforce Analysis
Traditionally, organizations such as Johnson Johnson use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Johnson Johnson within its industry.Johnson Johnson Manpower Efficiency
Return on Johnson Johnson Manpower
| Revenue Per Employee | 621.8K | |
| Revenue Per Executive | 9.5B | |
| Net Income Per Employee | 117.5K | |
| Net Income Per Executive | 1.8B |
Complementary Tools for Johnson Stock analysis
When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |